• Own the end-to-end operational transfer pricing calendar and implement BridgeBio’s global transfer pricing policies across the company’s decentralized research, clinical, commercial, and international activities.
• Build and maintain legal-entity and transaction-level transfer pricing models, including segmented profit-and-loss statements, cost pools, allocation keys, markups, tested-party results, target margins, arm’s-length ranges, and variance analyses.
• Prepare and maintain transfer pricing documentation, including functional and risk analyses, benchmarking studies, Master File and Local Files, Country-by-Country Reporting inputs, intercompany agreements, and contemporaneous support for material positions.
• Monitor U.S. and international transfer pricing developments and lead responses to tax authority inquiries, audits, and information requests with external advisors and Legal; maintain defensible workpapers and audit-ready data trails.
• Own recurring transfer pricing forecasts, calculations, allocations, invoices, settlements, and true-ups; reconcile results to intercompany accounts and the general ledger and coordinate timely entries with Controllership and affiliate finance teams.
• Monitor entity profitability and intercompany results throughout the year; investigate root causes, recommend operational corrections, and execute quarter-end and year-end adjustments in coordination with Accounting, FP&A, Treasury, and affiliate finance teams.
• Build transfer pricing forecasts by legal entity, jurisdiction, and transaction type and integrate forecasted intercompany charges, margins, settlements, and withholding taxes into consolidated ETR and cash-tax projections.
• Provide ad hoc analytics support to the broader tax team—such as book/tax difference analysis, provision reconciliations, and general ledger queries—using the same data pipelines and tools built for transfer pricing forecasting.